A polyphenolic green tea flavonol, epigallocatechin-3-gallate (EGCG), is a DYRK1A inhibitor that was shown to normalize DYRK1A activity in Down syndrome patients in a pilot study reversing cognitive deficits [168]. The gene discussed is DYRK1A; the disease is Cognitive impairment.